Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BYBrain Stimulation

Transdiagnostic efficacy, durability, and optimal parameters of rTMS for cognitive rehabilitation: A comprehensive meta-analysis

6 affiliations
  1. 1Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK
  2. 2Anatomy & Neurosciences, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Brain Tumor Center, Amsterdam, the Netherlands
  3. 3Department of Pain Medicine, The Walton Centre NHS Foundation Trust, UK
  4. 4Cancer Center Amsterdam, Brain Tumor Center, Amsterdam, the Netherlands; Medical Psychology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
  5. 5Cancer Center Amsterdam, Brain Tumor Center, Amsterdam, the Netherlands; Neurosurgery, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
  6. 6Anatomy & Neurosciences, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Cancer Center Amsterdam, Brain Tumor Center, Amsterdam, the Netherlands; Amsterdam Neuroscience, Amsterdam, the Netherlands; Corresponding author. Anatomy & Neurosciences Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Abstract

Aim: Repetitive Transcranial Magnetic Stimulation (rTMS) is a promising non-invasive neuromodulation technique for cognitive rehabilitation. We evaluated the cognitive effects of rTMS on neurological and psychiatric diseases to determine moderators of efficacy. Methods: A meta-analysis of Randomized Controlled Trials (RCTs) comparing real versus sham rTMS to July 2025 was performed. Objective cognition reported as primary or secondary outcomes were extracted and Hedges’ g effect sizes computed. Univariate and multivariate three-level meta-analyses were performed to estimate pooled effect sizes and assess moderator influence. Results: 748 measures from 137 studies (5972 participants) were extracted. Real rTMS produced a significant cognitive enhancement (g = 0.28, p < 0.0001, I 2 = 37.3%). This was durable over 2-52 weeks follow-up. There was efficacy across all cognitive domains (g > 0.20, I 2 = 35.8). Neurodegenerative (g = 0.35) and focal (g = 0.44) conditions demonstrated stronger effects than psychiatric conditions (g = 0.20). Although stimulation target was not a significant moderator overall, the Inferior Frontal Gyrus showed the largest effect (g = 0.45), with significant effects also at the left and right DLPFC and left parietal cortex (g = 0.29–0.45), all nodes of the Frontoparietal Network. 1-Hz stimulation produced a significantly larger effect (g = 0.39) than the 10-Hz reference (g = 0.19); 5-Hz, 20-Hz and iTBS were also significantly positive (g = 0.30–0.49). In multivariate models, adding 10 rTMS sessions improved cognitive outcomes (Δg = +0.077), whereas increasing the number of pulses per session trended toward reduced efficacy. All effects were confirmed in a left dorsolateral prefrontal cortex subgroup analysis. Subjective cognition was measured in only 6% of studies. A multivariate prediction tool is introduced: https://amsali.shinyapps.io/tms_cognition_prediction/ Conclusion: This meta-analysis demonstrates the sustained efficacy of rTMS in enhancing cognitive function, with small-to-moderate effect sizes across diverse clinical populations and stimulation protocols. However, a significant gap remains regarding whether these objective neurocognitive gains translate into meaningful improvements in subjective cognition or functional outcomes.

Related

  1. Beyond illness severity: transdiagnostic cognitive vulnerabilities as independent predictors of psychological distress in parents of children with rare genetic disorders
    Goran Cuturilo, Tatjana Vukosavljevic Gvozden, Matija Gvozden +2
    Frontiers in psychiatryPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMC
  2. A transdiagnostic computational account linking mental fatigue and cognitive effort
    Yang Yang, Akina Umemoto, Senne Braem +1
    PsyArXivPreprintCC BY 4.0Full textPsychiatry & mental healthOSF
  3. Cognitive transfer and durability of computerised cognitive training in older adults with mild cognitive impairment: a systematic review and meta-analysis of randomised controlled trials
    Hao Luo, Lin Deng, Lingyun Long +3
    Frontiers in aging neurosciencePeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMCEurope PMCPMC
  4. Comprehensive Multimodal Diagnostics and Rehabilitation in Persistent Post-Concussion Syndrome Following Motor Vehicle Collision
    Kenneth Jay, Mary Shaya, Jonathan Walker
    Journal of medical casesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Brain-computer interfaces for neurodegenerative diseases: A comprehensive review of closed-loop systems from diagnosis to neural rehabilitation
    Qingyang Shan, Jiaqi Li, Yi Wang +5
    iSciencePeer-reviewedCC BY-NC 4.0NeurologyCell PressCrossref
BibTeX
@article{ali2026transdiagnostic,
  title = {{Transdiagnostic efficacy, durability, and optimal parameters of rTMS for cognitive rehabilitation: A comprehensive meta-analysis}},
  author = {Ahmad M.S. Ali and Maxine Gorter and Rasheed Zakaria and Michael D. Jenkinson and Bernhard Frank and Martin Klein and Philip C. de Witt Hamer and Linda Douw},
  journal = {Brain Stimulation},
  year = {2026},
  month = oct,
  doi = {10.1016/j.brs.2026.103226},
  url = {https://doi.org/10.1016/j.brs.2026.103226},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Transdiagnostic efficacy, durability, and optimal parameters of rTMS for cognitive rehabilitation: A comprehensive meta-analysis
AU  - Ahmad M.S. Ali
AU  - Maxine Gorter
AU  - Rasheed Zakaria
AU  - Michael D. Jenkinson
AU  - Bernhard Frank
AU  - Martin Klein
AU  - Philip C. de Witt Hamer
AU  - Linda Douw
PY  - 2026
DA  - 2026/10/30
JO  - Brain Stimulation
DO  - 10.1016/j.brs.2026.103226
UR  - https://doi.org/10.1016/j.brs.2026.103226
AB  - Aim: Repetitive Transcranial Magnetic Stimulation (rTMS) is a promising non-invasive neuromodulation technique for cognitive rehabilitation. We evaluated the cognitive effects of rTMS on neurological and psychiatric diseases to determine moderators of efficacy. Methods: A meta-analysis of Randomized Controlled Trials (RCTs) comparing real versus sham rTMS to July 2025 was performed. Objective cognition reported as primary or secondary outcomes were extracted and Hedges’ g effect sizes computed. Univariate and multivariate three-level meta-analyses were performed to estimate pooled effect sizes and assess moderator influence. Results: 748 measures from 137 studies (5972 participants) were extracted. Real rTMS produced a significant cognitive enhancement (g = 0.28, p < 0.0001, I 2 = 37.3%). This was durable over 2-52 weeks follow-up. There was efficacy across all cognitive domains (g > 0.20, I 2 = 35.8). Neurodegenerative (g = 0.35) and focal (g = 0.44) conditions demonstrated stronger effects than psychiatric conditions (g = 0.20). Although stimulation target was not a significant moderator overall, the Inferior Frontal Gyrus showed the largest effect (g = 0.45), with significant effects also at the left and right DLPFC and left parietal cortex (g = 0.29–0.45), all nodes of the Frontoparietal Network. 1-Hz stimulation produced a significantly larger effect (g = 0.39) than the 10-Hz reference (g = 0.19); 5-Hz, 20-Hz and iTBS were also significantly positive (g = 0.30–0.49). In multivariate models, adding 10 rTMS sessions improved cognitive outcomes (Δg = +0.077), whereas increasing the number of pulses per session trended toward reduced efficacy. All effects were confirmed in a left dorsolateral prefrontal cortex subgroup analysis. Subjective cognition was measured in only 6% of studies. A multivariate prediction tool is introduced: https://amsali.shinyapps.io/tms_cognition_prediction/ Conclusion: This meta-analysis demonstrates the sustained efficacy of rTMS in enhancing cognitive function, with small-to-moderate effect sizes across diverse clinical populations and stimulation protocols. However, a significant gap remains regarding whether these objective neurocognitive gains translate into meaningful improvements in subjective cognition or functional outcomes.
SN  - 1935-861X
SN  - 1876-4754
ER  -